阿拉丁：拟认购雅酶生物25%股权

Core Viewpoint - Aladdin plans to acquire a 25% stake in Shanghai Yamei Biotechnology Co., Ltd through a two-step investment process [1] Group 1: Investment Details - The first step involves an investment of 24.7 million yuan to obtain 15% equity after the capital increase [1] - The second step includes acquiring 10% equity from existing shareholders for a total consideration of 16.47 million yuan [1] - The total investment amounts to 41.17 million yuan, funded by the company's own resources [1] Group 2: Company Profile - Shanghai Yamei Biotechnology Co., Ltd specializes in the research and production of scientific tools in the life sciences sector [1] - The company's business scope includes antibodies, protein reagents, and cell biology products [1]